May 1st 2024
A recent meta-analysis drew limited conclusions about the impact of 1-night sleep restriction on cognitive function, stressing the need for further research consideration.
The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights
1.0 Credit / Neurology
View More
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention
3.0 Credits / Neurology
View More
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
June 27, 2024 | 1:00 & 7:00 PM EDT
View More
Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
1.0 Credit / Neurology
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances
2.0 Credits / Neurology
View More
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
1.0 Credit / Neurology
View More
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
1.5 Credits / Neurology
View More
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
1.5 Credits / Neurology
View More
Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use
Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.
Read More
Poor Sleep, Extreme Sleep Duration Linked With Past COVID-19 Infection
April 20th 2023A recent study observed that poor sleep quality and having very little or a lot of sleep were associated with greater likelihood of having had COVID-19 in the past, while poor sleep quality was linked with an increased requirement of hospitalization for severe COVID-19.
Read More
As More Survive Cancer, Issues With Sleep, Fatigue, Cognitive Function on the Rise
April 15th 2023The April 2 plenary session at the National Comprehensive Cancer Network (NCCN) 2023 Annual Conference, entitled, “Sleep Disorders, Fatigue, and Cognitive Function in Cancer Survivors" reviewed guidelines for handling symptoms that are increasingly common as the survivorship ranks grow.
Read More
A Balancing Challenge: Social Relationships in the Life of Adolescents With Narcolepsy
April 2nd 2023Anne Marie Morse, DO, a pediatric neurologist and sleep medicine specialist at Geisinger Medical Center, talked about the challenges that adolescents with narcolepsy face in their social relationships.
Read More
High Prevalence of Anxiety, Depression in Patients With Narcolepsy Suggests Biological Relationship
March 7th 2023The high prevalence of anxiety and depression in patients with narcolepsy suggests that a biological relationship is present between the disorders, but larger studies are needed.
Read More
Telemonitoring Might Improve CPAP Adherence for Patients With OSA
February 6th 2023Telemonitoring may help improve continuous positive airway pressure (CPAP) therapy adherence for patients with obstructive sleep apnea syndrome (OSA), while motivational enhancement therapy (MET) most significantly impacted long-term adherence, according to a recent study.
Read More
No difference in treatment efficacy was observed between intranasal mometasone furoate and saline for the management of sleep-disordered breathing (SDB) symptoms in children, with findings indicating that almost one-half of children with SDB could be initially managed in the primary care setting.
Read More
Sleep Studies Needed to Confirm Subjective Improvement in OSA Symptoms After MAD Use
December 14th 2022Patients who used a mandibular advancement device (MAD) to address their obstructive sleep apnea (OSA) symptoms reported improvement in their sleep quality and tiredness on waking even if their sleep criteria did not indicate a response to treatment, indicating the importance of a posttreatment sleep study to ensure MAD efficacy.
Read More
Caregiver Knowledge of AAP Guidelines Improved OSA Outcomes in People With Down Syndrome
December 2nd 2022A study found that people with Down syndrome with caregivers who were aware of the updated American Academy of Pediatrics (AAP) guidelines on screening for obstructive sleep apnea (OSA) were diagnosed earlier and had better health outcomes for OSA.
Read More